Monthly Archives: November 2023
Cardiovascular
Semaglutide cuts cardiovascular risk by 20% in people with heart disease, obesity: SELECT
Nov
November 11, 2023 4 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . <button type="button" class="btn btn-primary" data-loading-text="Loading ” data-action=”subscribe”> Subscribe Added to email alerts We were unable to process your request. […]
Nov
The weight-loss drug Wegovy reduces the risk of experiencing or dying from events like heart attacks and strokes by 20 percent in people with obesity and preexisting heart disease, according to results from a late-stage clinical trial published in The New England Journal of Medicine. For the study, scientists randomly assigned 17,604 people with obesity […]
Blood
A neck-sparing short stem shows significantly lower blood loss in total hip arthroplasty compared to a neck-resecting short stem
Nov
Abstract Short stems are associated with a significantly lower blood loss (BL) compared to straight stems in total hip arthroplasty (THA). Different types of stems differ in design, fixation and level of femoral neck osteotomy. Therefore, we sought to evaluate the difference regarding the perioperative BL between two short stems with different designs in direct […]
Nov
PHILADELPHIA — An enormous swath of Americans can be expected to get secondary cardiovascular prevention benefits from weekly semaglutide (Wegovy) injections based on the SELECT trial. Even in the absence of diabetes, overweight and obese people with pre-existing cardiovascular disease had the advantage of a substantially lower incidence of combined death from cardiovascular causes, myocardial […]